Send the following on WhatsApp
Continue to ChatI liked this article on M3 India: 8-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population. Have a read: https://www.m3india.in/contents/journal/8-year-survival-in-chronic-hepatitis-b-patients?utm_campaign=unset&utm_medium=share&utm_source=ref_wa